Loïc Le Guennec

17PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 02, 2026
Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

|Feb 17, 2026
Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Charleen Robert, Dimitri Psimaras, Sylvain Choquet

|Jun 13, 2025
Blood-brain barrier dysfunction in hepatic encephalopathy: pathophysiology, diagnostic assessment and therapeutic perspectives.

Loic Le Guennec, Sarah Mouri, Dominique Thabut

|Apr 30, 2025
Predicting intrathecal immunoglobulin synthesis in the ICU: a comparative study of IgG-based indexes.

Alexander Balcerac, Clémence Marois, Delphine Sterlin

|Mar 27, 2025
Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Hugo Hernández-Tost, Nicolas Weiss, Sylvain Choquet

|Jun 25, 2024
REM and NREM Sleep Parasomnia in Anti-NMDA Receptor Encephalitis.

Luis Ribeiro, Dimitri Psimaras, Raphael Vollhardt

Pageof 3

Frequent Collaborators

4 joint publications

Nicolas Weiss

3 joint publications

Dimitri Psimaras

2 joint publications

Cristina Birzu

2 joint publications

Khê Hoang-Xuan